Does Changes in the Muscles Beneath the Submucosal Tissues Necessitate a Novel Strategy in the Medical Management of

Uday Kiran Uppada1

  • 1Department of Dentistry, All India Institute of Medical Sciences, Nagpur, India.

Insights

Oral submucous fibrosis (OSMF) causes muscle degeneration, primarily affecting the masseter muscle. This muscle involvement, linked to habit duration, contributes significantly to restricted mouth opening in OSMF patients.

Area of Science:

  • Oral pathology and maxillofacial surgery
  • Muscle physiology and disease mechanisms
  • Systematic review methodology

Background:

  • Oral submucous fibrosis (OSMF) is a chronic, potentially malignant disorder characterized by juxta-epithelial inflammation, fibroblast hyperplasia, and collagen deposition.
  • Submucosal fibrosis leads to progressive restriction of jaw movements, significantly impacting patients' quality of life.
  • The role of muscle structural changes in OSMF pathogenesis and treatment is not fully elucidated.

Purpose of the Study:

  • To systematically review and assess the structural changes in masticatory and facial muscles in oral submucous fibrosis.
  • To determine if these muscular alterations necessitate novel treatment strategies beyond conventional modalities.

Main Methods:

  • A systematic literature search was conducted across Medline, EMBASE, and CENTRAL databases up to April 2024.
  • Included studies focused on oral submucous fibrosis and muscular changes, utilizing histopathologic, ultrasonographic, CT, or MRI data.
  • Seven studies met the inclusion criteria for data extraction and analysis.

Main Results:

  • The masseter muscle was identified as the most frequently affected masticatory muscle in OSMF.
  • Muscle degeneration and disease progression showed a direct correlation with the duration of the causative habit.
  • Restricted mouth opening in OSMF is influenced by both subepithelial fibrosis and the extent of muscle degeneration.

Conclusions:

  • Muscle degeneration is a significant component of oral submucous fibrosis, contributing to functional impairment.
  • The findings suggest that therapeutic strategies for OSMF may need to address muscular changes alongside fibrotic tissue.
  • Further research is needed to evaluate the buccinator muscle's involvement and to develop targeted muscle-based treatments.